Given the significant projected growth in the ethnic food market and the recent upgrades for Associated British Foods (ASBFY) to a Strong Buy rating, I believe that the stock may be overvalued at this point. Therefore, I see a short position as a strategic move before a potential correction occurs.

Given the robust growth forecast for the biopharmaceutical excipients market and the recent upgrade to a Strong Buy by Zacks, I expect ASBFY's stock price to increase significantly over the coming months, creating an opportunity for gains through a short position.